热门资讯> 正文

Arvinas任命Andrew Saik为首席财务官

2024-06-25 04:41

Arvinas (NASDAQ:ARVN) on Monday announced the appointment of Andrew Saik to the role of Chief Financial Officer and Treasurer.
Saik, most recently, served as CFO at Intercept Pharmaceuticals. Prior to Intercept Pharmaceuticals, he was CFO of Vyne Therapeutics.
Source: Press Release

More on Arvinas

Arvinas And Novartis Partnering On Prostate Cancer Protein Degrader Is A Win-Win Situation
Financial information for Arvinas

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。